Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
申请人:Bernotas Charles Ronald
公开号:US20080015201A1
公开(公告)日:2008-01-17
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。
HETEROCYCLYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:EP1592690A1
公开(公告)日:2005-11-09
COMBINATION OF A CHOLINESTERASE INHIBITOR AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY